Shopping Cart 0
Cart Subtotal
AED 0

Global mRNA Vaccines & Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 17910

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 35819
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

 

Scope of the Report:

mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.

Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.

The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.

The worldwide market for mRNA Vaccines & Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2024, from xx million USD in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the mRNA Vaccines & Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

 

Market Segment by Manufacturers, this report covers

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

 

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

 

Market Segment by Type, covers

Standardization Of Cancer Treatment MRNA Vaccine

Individualized Cancer Treatment MRNA Vaccine

Infectious Disease Treatment MRNA Vaccine

Infection Prevention MRNA Vaccine

 

Market Segment by Applications, can be divided into

Infectious Disease

Cancer

Other

 

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe mRNA Vaccines & Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of mRNA Vaccines & Therapeutics, with price, sales, revenue and global market share of mRNA Vaccines & Therapeutics in 2017 and 2018.

Chapter 3, the mRNA Vaccines & Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the mRNA Vaccines & Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, mRNA Vaccines & Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe mRNA Vaccines & Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Table Of Content

Scope

Table of Contents

 

1 Market Overview

1.1 mRNA Vaccines & Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Standardization Of Cancer Treatment MRNA Vaccine

1.2.2 Individualized Cancer Treatment MRNA Vaccine

1.2.3 Infectious Disease Treatment MRNA Vaccine

1.2.4 Infection Prevention MRNA Vaccine

1.3 Market Analysis by Applications

1.3.1 Infectious Disease

1.3.2 Cancer

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Moderna Therapeutics

2.1.1 Business Overview

2.1.2 mRNA Vaccines & Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 CureVac

2.2.1 Business Overview

2.2.2 mRNA Vaccines & Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Translate Bio

2.3.1 Business Overview

2.3.2 mRNA Vaccines & Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 BioNTech

2.4.1 Business Overview

2.4.2 mRNA Vaccines & Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Sangamo Therapeutics

2.5.1 Business Overview

2.5.2 mRNA Vaccines & Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Argos Therapeutics

2.6.1 Business Overview

2.6.2 mRNA Vaccines & Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 In-Cell-Art

2.7.1 Business Overview

2.7.2 mRNA Vaccines & Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 eTheRNA

2.8.1 Business Overview

2.8.2 mRNA Vaccines & Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Ethris

2.9.1 Business Overview

2.9.2 mRNA Vaccines & Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Tiba Biotechnology

2.10.1 Business Overview

2.10.2 mRNA Vaccines & Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global mRNA Vaccines & Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Manufacturer (2017-2018)

3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2018

3.3.2 Top 6 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global mRNA Vaccines & Therapeutics Market Analysis by Regions

4.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Regions

4.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Regions (2014-2019)

4.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Regions (2014-2019)

4.2 North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

4.3 Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

4.5 South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

5 North America mRNA Vaccines & Therapeutics by Country

5.1 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country

5.1.1 North America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)

5.1.2 North America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)

5.2 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

5.3 Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

5.4 Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

6 Europe mRNA Vaccines & Therapeutics by Country

6.1 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country

6.1.1 Europe mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)

6.1.2 Europe mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)

6.2 Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

6.3 UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

6.4 France mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

6.5 Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

6.6 Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

7 Asia-Pacific mRNA Vaccines & Therapeutics by Country

7.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)

7.2 China mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

7.3 Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

7.4 Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

7.5 India mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

7.6 Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

8 South America mRNA Vaccines & Therapeutics by Country

8.1 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country

8.1.1 South America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)

8.1.2 South America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)

8.2 Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

8.3 Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

8.4 Colombia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

9 Middle East and Africa mRNA Vaccines & Therapeutics by Countries

9.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

9.3 Turkey mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

9.4 Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

9.5 Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

9.6 South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

10 Global mRNA Vaccines & Therapeutics Market Segment by Type

10.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2014-2019)

10.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2014-2019)

10.2 Standardization Of Cancer Treatment MRNA Vaccine Sales Growth and Price

10.2.1 Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)

10.2.2 Global Standardization Of Cancer Treatment MRNA Vaccine Price (2014-2019)

10.3 Individualized Cancer Treatment MRNA Vaccine Sales Growth and Price

10.3.1 Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)

10.3.2 Global Individualized Cancer Treatment MRNA Vaccine Price (2014-2019)

10.4 Infectious Disease Treatment MRNA Vaccine Sales Growth and Price

10.4.1 Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2014-2019)

10.4.2 Global Infectious Disease Treatment MRNA Vaccine Price (2014-2019)

10.5 Infection Prevention MRNA Vaccine Sales Growth and Price

10.5.1 Global Infection Prevention MRNA Vaccine Sales Growth (2014-2019)

10.5.2 Global Infection Prevention MRNA Vaccine Price (2014-2019)

11 Global mRNA Vaccines & Therapeutics Market Segment by Application

11.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2014-2019)

11.2 Infectious Disease Sales Growth (2014-2019)

11.3 Cancer Sales Growth (2014-2019)

11.4 Other Sales Growth (2014-2019)

12 mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

12.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2019-2024)

12.2 mRNA Vaccines & Therapeutics Market Forecast by Regions (2019-2024)

12.2.1 North America mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

12.2.2 Europe mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

12.2.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

12.2.4 South America mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

12.2.5 Middle East and Africa mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

12.3 mRNA Vaccines & Therapeutics Market Forecast by Type (2019-2024)

12.3.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2019-2024)

12.3.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2019-2024)

12.4 mRNA Vaccines & Therapeutics Market Forecast by Application (2019-2024)

12.4.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2019-2024)

12.4.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

 

Figure mRNA Vaccines & Therapeutics Picture

Table Product Specifications of mRNA Vaccines & Therapeutics

Figure Global Sales Market Share of mRNA Vaccines & Therapeutics by Types in 2018

Table mRNA Vaccines & Therapeutics Types for Major Manufacturers

Figure Standardization Of Cancer Treatment MRNA Vaccine Picture

Figure Individualized Cancer Treatment MRNA Vaccine Picture

Figure Infectious Disease Treatment MRNA Vaccine Picture

Figure Infection Prevention MRNA Vaccine Picture

Figure mRNA Vaccines & Therapeutics Sales Market Share by Applications in 2018

Figure Infectious Disease Picture

Figure Cancer Picture

Figure Other Picture

Figure United States mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Canada mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Germany mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure France mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure UK mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Russia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Italy mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure China mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Japan mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Korea mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure India mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Table Moderna Therapeutics Basic Information, Manufacturing Base and Competitors

Table Moderna Therapeutics mRNA Vaccines & Therapeutics Type and Applications

Table Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table CureVac Basic Information, Manufacturing Base and Competitors

Table CureVac mRNA Vaccines & Therapeutics Type and Applications

Table CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Translate Bio Basic Information, Manufacturing Base and Competitors

Table Translate Bio mRNA Vaccines & Therapeutics Type and Applications

Table Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table BioNTech Basic Information, Manufacturing Base and Competitors

Table BioNTech mRNA Vaccines & Therapeutics Type and Applications

Table BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors

Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Type and Applications

Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Argos Therapeutics Basic Information, Manufacturing Base and Competitors

Table Argos Therapeutics mRNA Vaccines & Therapeutics Type and Applications

Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table In-Cell-Art Basic Information, Manufacturing Base and Competitors

Table In-Cell-Art mRNA Vaccines & Therapeutics Type and Applications

Table In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table eTheRNA Basic Information, Manufacturing Base and Competitors

Table eTheRNA mRNA Vaccines & Therapeutics Type and Applications

Table eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Ethris Basic Information, Manufacturing Base and Competitors

Table Ethris mRNA Vaccines & Therapeutics Type and Applications

Table Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Tiba Biotechnology Basic Information, Manufacturing Base and Competitors

Table Tiba Biotechnology mRNA Vaccines & Therapeutics Type and Applications

Table Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global mRNA Vaccines & Therapeutics Sales by Manufacturer (2017-2018)

Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017

Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2018

Table Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2017-2018)

Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017

Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2018

Figure Top 3 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2018

Figure Top 6 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2018

Figure Global mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Global mRNA Vaccines & Therapeutics Revenue and Growth Rate (2014-2019)

Table Global mRNA Vaccines & Therapeutics Sales by Regions (2014-2019)

Table Global mRNA Vaccines & Therapeutics Sales Market Share by Regions (2014-2019)

Table Global mRNA Vaccines & Therapeutics Revenue by Regions (2014-2019)

Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2014

Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2018

Figure North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure North America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2014-2019)

Table North America mRNA Vaccines & Therapeutics Sales by Countries (2014-2019)

Table North America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2014-2019)

Figure North America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2014

Figure North America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2018

Table North America mRNA Vaccines & Therapeutics Revenue by Countries (2014-2019)

Table North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2014-2019)

Figure North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2014

Figure North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2018

Figure United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2014-2019)

Table Europe mRNA Vaccines & Therapeutics Sales by Countries (2014-2019)

Table Europe mRNA Vaccines & Therapeutics Sales Market Share by Countries (2014-2019)

Table Europe mRNA Vaccines & Therapeutics Revenue by Countries (2014-2019)

Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2017

Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2018

Figure Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure France mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate (2014-2019)

Table Asia-Pacific mRNA Vaccines & Therapeutics Sales by Countries (2014-2019)

Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Countries 2018

Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Countries (2014-2019)

Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Countries 2018

Figure China mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure India mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure South America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2014-2019)

Table South America mRNA Vaccines & Therapeutics Sales by Countries (2014-2019)

Table South America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2014-2019)

Figure South America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2018

Table South America mRNA Vaccines & Therapeutics Revenue by Countries (2014-2019)

Table South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2014-2019)

Figure South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2018

Figure Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Colombia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2014-2019)

Table Middle East and Africa mRNA Vaccines & Therapeutics Sales by Countries (2014-2019)

Table Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2018

Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Countries (2014-2019)

Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2014

Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2018

Figure Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure UAE mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Table Global mRNA Vaccines & Therapeutics Sales by Type (2014-2019)

Table Global mRNA Vaccines & Therapeutics Sales Share by Type (2014-2019)

Table Global mRNA Vaccines & Therapeutics Revenue by Type (2014-2019)

Table Global mRNA Vaccines & Therapeutics Revenue Share by Type (2014-2019)

Figure Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)

Figure Global Standardization Of Cancer Treatment MRNA Vaccine Price (2014-2019)

Figure Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)

Figure Global Individualized Cancer Treatment MRNA Vaccine Price (2014-2019)

Figure Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2014-2019)

Figure Global Infectious Disease Treatment MRNA Vaccine Price (2014-2019)

Figure Global Infection Prevention MRNA Vaccine Sales Growth (2014-2019)

Figure Global Infection Prevention MRNA Vaccine Price (2014-2019)

Table Global mRNA Vaccines & Therapeutics Sales by Application (2014-2019)

Table Global mRNA Vaccines & Therapeutics Sales Share by Application (2014-2019)

Figure Global Cancer Sales Growth (2014-2019)

Figure Global Other Sales Growth (2014-2019)

Figure Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2019-2024)

Table Global mRNA Vaccines & Therapeutics Sales Forecast by Regions (2019-2024)

Table Global mRNA Vaccines & Therapeutics Market Share Forecast by Regions (2019-2024)

Figure North America Sales mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

Figure Europe Sales mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

Figure Asia-Pacific Sales mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

Figure South America Sales mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

Figure Middle East and Africa Sales mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

Table Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2019-2024)

Table Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2019-2024)

Table Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2019-2024)

Table Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

 

Scope of the Report:

mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.

Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.

The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.

The worldwide market for mRNA Vaccines & Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2024, from xx million USD in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the mRNA Vaccines & Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

 

Market Segment by Manufacturers, this report covers

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

 

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

 

Market Segment by Type, covers

Standardization Of Cancer Treatment MRNA Vaccine

Individualized Cancer Treatment MRNA Vaccine

Infectious Disease Treatment MRNA Vaccine

Infection Prevention MRNA Vaccine

 

Market Segment by Applications, can be divided into

Infectious Disease

Cancer

Other

 

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe mRNA Vaccines & Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of mRNA Vaccines & Therapeutics, with price, sales, revenue and global market share of mRNA Vaccines & Therapeutics in 2017 and 2018.

Chapter 3, the mRNA Vaccines & Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the mRNA Vaccines & Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, mRNA Vaccines & Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe mRNA Vaccines & Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Scope

Table of Contents

 

1 Market Overview

1.1 mRNA Vaccines & Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Standardization Of Cancer Treatment MRNA Vaccine

1.2.2 Individualized Cancer Treatment MRNA Vaccine

1.2.3 Infectious Disease Treatment MRNA Vaccine

1.2.4 Infection Prevention MRNA Vaccine

1.3 Market Analysis by Applications

1.3.1 Infectious Disease

1.3.2 Cancer

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Moderna Therapeutics

2.1.1 Business Overview

2.1.2 mRNA Vaccines & Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 CureVac

2.2.1 Business Overview

2.2.2 mRNA Vaccines & Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Translate Bio

2.3.1 Business Overview

2.3.2 mRNA Vaccines & Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 BioNTech

2.4.1 Business Overview

2.4.2 mRNA Vaccines & Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Sangamo Therapeutics

2.5.1 Business Overview

2.5.2 mRNA Vaccines & Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Argos Therapeutics

2.6.1 Business Overview

2.6.2 mRNA Vaccines & Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 In-Cell-Art

2.7.1 Business Overview

2.7.2 mRNA Vaccines & Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 eTheRNA

2.8.1 Business Overview

2.8.2 mRNA Vaccines & Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Ethris

2.9.1 Business Overview

2.9.2 mRNA Vaccines & Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Tiba Biotechnology

2.10.1 Business Overview

2.10.2 mRNA Vaccines & Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global mRNA Vaccines & Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Manufacturer (2017-2018)

3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2018

3.3.2 Top 6 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global mRNA Vaccines & Therapeutics Market Analysis by Regions

4.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Regions

4.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Regions (2014-2019)

4.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Regions (2014-2019)

4.2 North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

4.3 Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

4.5 South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

5 North America mRNA Vaccines & Therapeutics by Country

5.1 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country

5.1.1 North America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)

5.1.2 North America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)

5.2 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

5.3 Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

5.4 Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

6 Europe mRNA Vaccines & Therapeutics by Country

6.1 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country

6.1.1 Europe mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)

6.1.2 Europe mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)

6.2 Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

6.3 UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

6.4 France mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

6.5 Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

6.6 Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

7 Asia-Pacific mRNA Vaccines & Therapeutics by Country

7.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)

7.2 China mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

7.3 Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

7.4 Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

7.5 India mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

7.6 Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

8 South America mRNA Vaccines & Therapeutics by Country

8.1 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country

8.1.1 South America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)

8.1.2 South America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)

8.2 Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

8.3 Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

8.4 Colombia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

9 Middle East and Africa mRNA Vaccines & Therapeutics by Countries

9.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

9.3 Turkey mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

9.4 Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

9.5 Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

9.6 South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

10 Global mRNA Vaccines & Therapeutics Market Segment by Type

10.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2014-2019)

10.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2014-2019)

10.2 Standardization Of Cancer Treatment MRNA Vaccine Sales Growth and Price

10.2.1 Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)

10.2.2 Global Standardization Of Cancer Treatment MRNA Vaccine Price (2014-2019)

10.3 Individualized Cancer Treatment MRNA Vaccine Sales Growth and Price

10.3.1 Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)

10.3.2 Global Individualized Cancer Treatment MRNA Vaccine Price (2014-2019)

10.4 Infectious Disease Treatment MRNA Vaccine Sales Growth and Price

10.4.1 Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2014-2019)

10.4.2 Global Infectious Disease Treatment MRNA Vaccine Price (2014-2019)

10.5 Infection Prevention MRNA Vaccine Sales Growth and Price

10.5.1 Global Infection Prevention MRNA Vaccine Sales Growth (2014-2019)

10.5.2 Global Infection Prevention MRNA Vaccine Price (2014-2019)

11 Global mRNA Vaccines & Therapeutics Market Segment by Application

11.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2014-2019)

11.2 Infectious Disease Sales Growth (2014-2019)

11.3 Cancer Sales Growth (2014-2019)

11.4 Other Sales Growth (2014-2019)

12 mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

12.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2019-2024)

12.2 mRNA Vaccines & Therapeutics Market Forecast by Regions (2019-2024)

12.2.1 North America mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

12.2.2 Europe mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

12.2.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

12.2.4 South America mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

12.2.5 Middle East and Africa mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

12.3 mRNA Vaccines & Therapeutics Market Forecast by Type (2019-2024)

12.3.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2019-2024)

12.3.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2019-2024)

12.4 mRNA Vaccines & Therapeutics Market Forecast by Application (2019-2024)

12.4.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2019-2024)

12.4.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

 

Figure mRNA Vaccines & Therapeutics Picture

Table Product Specifications of mRNA Vaccines & Therapeutics

Figure Global Sales Market Share of mRNA Vaccines & Therapeutics by Types in 2018

Table mRNA Vaccines & Therapeutics Types for Major Manufacturers

Figure Standardization Of Cancer Treatment MRNA Vaccine Picture

Figure Individualized Cancer Treatment MRNA Vaccine Picture

Figure Infectious Disease Treatment MRNA Vaccine Picture

Figure Infection Prevention MRNA Vaccine Picture

Figure mRNA Vaccines & Therapeutics Sales Market Share by Applications in 2018

Figure Infectious Disease Picture

Figure Cancer Picture

Figure Other Picture

Figure United States mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Canada mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Germany mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure France mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure UK mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Russia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Italy mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure China mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Japan mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Korea mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure India mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2014-2024)

Table Moderna Therapeutics Basic Information, Manufacturing Base and Competitors

Table Moderna Therapeutics mRNA Vaccines & Therapeutics Type and Applications

Table Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table CureVac Basic Information, Manufacturing Base and Competitors

Table CureVac mRNA Vaccines & Therapeutics Type and Applications

Table CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Translate Bio Basic Information, Manufacturing Base and Competitors

Table Translate Bio mRNA Vaccines & Therapeutics Type and Applications

Table Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table BioNTech Basic Information, Manufacturing Base and Competitors

Table BioNTech mRNA Vaccines & Therapeutics Type and Applications

Table BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors

Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Type and Applications

Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Argos Therapeutics Basic Information, Manufacturing Base and Competitors

Table Argos Therapeutics mRNA Vaccines & Therapeutics Type and Applications

Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table In-Cell-Art Basic Information, Manufacturing Base and Competitors

Table In-Cell-Art mRNA Vaccines & Therapeutics Type and Applications

Table In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table eTheRNA Basic Information, Manufacturing Base and Competitors

Table eTheRNA mRNA Vaccines & Therapeutics Type and Applications

Table eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Ethris Basic Information, Manufacturing Base and Competitors

Table Ethris mRNA Vaccines & Therapeutics Type and Applications

Table Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Tiba Biotechnology Basic Information, Manufacturing Base and Competitors

Table Tiba Biotechnology mRNA Vaccines & Therapeutics Type and Applications

Table Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global mRNA Vaccines & Therapeutics Sales by Manufacturer (2017-2018)

Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017

Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2018

Table Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2017-2018)

Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017

Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2018

Figure Top 3 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2018

Figure Top 6 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2018

Figure Global mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Global mRNA Vaccines & Therapeutics Revenue and Growth Rate (2014-2019)

Table Global mRNA Vaccines & Therapeutics Sales by Regions (2014-2019)

Table Global mRNA Vaccines & Therapeutics Sales Market Share by Regions (2014-2019)

Table Global mRNA Vaccines & Therapeutics Revenue by Regions (2014-2019)

Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2014

Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2018

Figure North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure North America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2014-2019)

Table North America mRNA Vaccines & Therapeutics Sales by Countries (2014-2019)

Table North America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2014-2019)

Figure North America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2014

Figure North America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2018

Table North America mRNA Vaccines & Therapeutics Revenue by Countries (2014-2019)

Table North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2014-2019)

Figure North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2014

Figure North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2018

Figure United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2014-2019)

Table Europe mRNA Vaccines & Therapeutics Sales by Countries (2014-2019)

Table Europe mRNA Vaccines & Therapeutics Sales Market Share by Countries (2014-2019)

Table Europe mRNA Vaccines & Therapeutics Revenue by Countries (2014-2019)

Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2017

Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2018

Figure Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure France mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate (2014-2019)

Table Asia-Pacific mRNA Vaccines & Therapeutics Sales by Countries (2014-2019)

Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Countries 2018

Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Countries (2014-2019)

Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Countries 2018

Figure China mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure India mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure South America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2014-2019)

Table South America mRNA Vaccines & Therapeutics Sales by Countries (2014-2019)

Table South America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2014-2019)

Figure South America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2018

Table South America mRNA Vaccines & Therapeutics Revenue by Countries (2014-2019)

Table South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2014-2019)

Figure South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2018

Figure Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Colombia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2014-2019)

Table Middle East and Africa mRNA Vaccines & Therapeutics Sales by Countries (2014-2019)

Table Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2018

Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Countries (2014-2019)

Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2014

Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2018

Figure Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure UAE mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Figure South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

Table Global mRNA Vaccines & Therapeutics Sales by Type (2014-2019)

Table Global mRNA Vaccines & Therapeutics Sales Share by Type (2014-2019)

Table Global mRNA Vaccines & Therapeutics Revenue by Type (2014-2019)

Table Global mRNA Vaccines & Therapeutics Revenue Share by Type (2014-2019)

Figure Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)

Figure Global Standardization Of Cancer Treatment MRNA Vaccine Price (2014-2019)

Figure Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)

Figure Global Individualized Cancer Treatment MRNA Vaccine Price (2014-2019)

Figure Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2014-2019)

Figure Global Infectious Disease Treatment MRNA Vaccine Price (2014-2019)

Figure Global Infection Prevention MRNA Vaccine Sales Growth (2014-2019)

Figure Global Infection Prevention MRNA Vaccine Price (2014-2019)

Table Global mRNA Vaccines & Therapeutics Sales by Application (2014-2019)

Table Global mRNA Vaccines & Therapeutics Sales Share by Application (2014-2019)

Figure Global Cancer Sales Growth (2014-2019)

Figure Global Other Sales Growth (2014-2019)

Figure Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2019-2024)

Table Global mRNA Vaccines & Therapeutics Sales Forecast by Regions (2019-2024)

Table Global mRNA Vaccines & Therapeutics Market Share Forecast by Regions (2019-2024)

Figure North America Sales mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

Figure Europe Sales mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

Figure Asia-Pacific Sales mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

Figure South America Sales mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

Figure Middle East and Africa Sales mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

Table Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2019-2024)

Table Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2019-2024)

Table Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2019-2024)

Table Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

chat_bubbleLet's Chat